These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23591459)

  • 1. One size does not fit all: personalized immune therapies poised to take center stage.
    Azvolinsky A
    J Natl Cancer Inst; 2013 May; 105(9):583-4. PubMed ID: 23591459
    [No Abstract]   [Full Text] [Related]  

  • 2. On target: genetically modified cells show promise in targeted immunotherapy for advanced blood cancers.
    Printz C
    Cancer; 2014 Apr; 120(7):929-30. PubMed ID: 24643628
    [No Abstract]   [Full Text] [Related]  

  • 3. Adoptive T cell therapy for cancer in the clinic.
    June CH
    J Clin Invest; 2007 Jun; 117(6):1466-76. PubMed ID: 17549249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
    Houot R; Schultz LM; Marabelle A; Kohrt H
    Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stay the course.
    Nat Med; 2014 Jun; 20(6):561. PubMed ID: 24901549
    [No Abstract]   [Full Text] [Related]  

  • 6. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
    Ikeda H
    Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive T cell therapy: Boosting the immune system to fight cancer.
    Leon E; Ranganathan R; Savoldo B
    Semin Immunol; 2020 Jun; 49():101437. PubMed ID: 33262066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CART trials are going ahead.
    Wei J; Han W
    Sci China Life Sci; 2017 Nov; 60(11):1276-1279. PubMed ID: 29170890
    [No Abstract]   [Full Text] [Related]  

  • 9. Extending the Promise of Chimeric Antigen Receptor T-Cell Therapy Beyond Targeting CD19
    Grover NS; Tschernia N; Dotti G; Savoldo B
    J Clin Oncol; 2021 Feb; 39(5):499-513. PubMed ID: 33434072
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in T-cell immunotherapy for haematological malignancies.
    Rouce RH; Sharma S; Huynh M; Heslop HE
    Br J Haematol; 2017 Mar; 176(5):688-704. PubMed ID: 27897332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive cellular immunotherapy of cancer.
    Winter H; Fox BA
    Curr Opin Mol Ther; 1999 Feb; 1(1):89-97. PubMed ID: 11249690
    [No Abstract]   [Full Text] [Related]  

  • 12. From the guest editor: The rise of CAR therapy: the CD19 paradigm, and beyond. Introduction.
    Sadelain M
    Cancer J; 2014; 20(2):105-6. PubMed ID: 24667953
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors.
    Feldman SA; Assadipour Y; Kriley I; Goff SL; Rosenberg SA
    Semin Oncol; 2015 Aug; 42(4):626-39. PubMed ID: 26320066
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic redirection of T cells for cancer therapy.
    Westwood JA; Kershaw MH
    J Leukoc Biol; 2010 May; 87(5):791-803. PubMed ID: 20179152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular immunotherapy of cancer].
    Kawakami Y
    Rinsho Ketsueki; 2003 Jun; 44(6):358-67. PubMed ID: 12884813
    [No Abstract]   [Full Text] [Related]  

  • 17. Adoptive T-cell immunotherapy of cancer.
    Li Q; Chang AE
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):105-17. PubMed ID: 10515683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunotherapy for hematological malignancies].
    Yasukawa M
    Rinsho Ketsueki; 2008 Oct; 49(10):1460-71. PubMed ID: 18833930
    [No Abstract]   [Full Text] [Related]  

  • 19. T lymphocyte therapy of cancer.
    Michálek J; Büchler T; Hájek R
    Physiol Res; 2004; 53(5):463-9. PubMed ID: 15479123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-modified T cells: CARs take the front seat for hematologic malignancies.
    Maus MV; Grupp SA; Porter DL; June CH
    Blood; 2014 Apr; 123(17):2625-35. PubMed ID: 24578504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.